Published in Clin Diagn Lab Immunol on September 01, 1997
MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLoS One (2013) 2.39
Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses (2010) 1.26
A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med (1994) 8.52
Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA (1993) 2.41
Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol (1995) 2.00
Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol (1996) 1.71
Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods (1995) 1.19
Shedding of HIV-1 in the genital tract. AIDS (1996) 1.17
Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis (2000) 3.21
Bleeding in renal failure: a possible cause. Br Med J (1976) 2.82
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32
[Idiopathic CD4 lymphocytopenia]. Presse Med (1994) 2.03
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
[Nomenclature in clinical chemistry. International recommendations concerning quantities, units and laboratory results]. Ann Biol Clin (Paris) (1972) 1.93
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis (2000) 1.86
In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immunol (1997) 1.69
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy. HIV Med (2008) 1.63
Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood (1996) 1.62
Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology (1998) 1.51
Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry (1998) 1.41
Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant (1993) 1.39
Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis (1993) 1.35
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis (2008) 1.35
High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol (1995) 1.33
Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun (1994) 1.28
[Determination of alpha-amylase by a microtechnic]. Ann Biol Clin (Paris) (1968) 1.27
Trends of AIDS epidemic in Cameroon, 1986 through 1995. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.27
Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers. Clin Diagn Lab Immunol (2000) 1.26
Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain (1994) 1.26
Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine (Baltimore) (1996) 1.24
Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. J Infect Dis (2001) 1.20
High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Hum Retroviruses (1997) 1.10
Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis (2000) 1.08
Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol (2001) 1.08
Hypocomplementemic urticarial vasculitis syndrome, Jaccoud's syndrome, valvulopathy: a new syndromic combination. J Rheumatol (1993) 1.06
Systemic and secretory humoral immunity in the normal human vaginal tract. Scand J Immunol (1995) 1.03
Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest (1985) 1.01
Antenatal HIV prevalence in Yaounde, Cameroon. Int J STD AIDS (1998) 0.98
Population dynamics of natural antibodies in normal and autoimmune individuals. Proc Natl Acad Sci U S A (1991) 0.98
Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group. AIDS (1997) 0.97
Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women. Clin Diagn Lab Immunol (2001) 0.97
Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J Immunol (2001) 0.96
Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa. AIDS (1999) 0.96
[Esophageal diverticula and therapeutic inefficacy]. Gastroenterol Clin Biol (1984) 0.94
Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation. Cell Regul (1991) 0.93
Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies. Clin Exp Immunol (2002) 0.92
Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS (1999) 0.92
Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV. AIDS (1999) 0.92
Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J Immunol (2001) 0.91
[Recurrent polyneuropathy with a 19-year course, associated with a benign IgG monoclonal gammapathy]. Rev Neurol (Paris) (1976) 0.89
[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. Presse Med (1988) 0.88
The human C3b receptor (CR1). Adv Nephrol Necker Hosp (1989) 0.88
Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch A Pathol Anat Histopathol (1989) 0.88
Spontaneous peritonitis in cirrhotic hospital in-patients: retrospective analysis of 101 cases. Q J Med (1992) 0.87
Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry. J Immunol Methods (1987) 0.87
HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet (1994) 0.87
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso. Sex Transm Infect (2007) 0.87
Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens. Scand J Immunol (2001) 0.87
Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I. J Med Virol (1996) 0.87
Association of herpes simplex virus encephalitis and paraneoplastic encephalitis - a clinico-pathological study. Ann Pathol (2000) 0.86
Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm. Nat Med (2003) 0.86
Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol (1998) 0.86
[Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine]. Gastroenterol Clin Biol (1997) 0.85
Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome. J Neuroimmunol (1996) 0.85
The slim disease in African patients with AIDS. Trans R Soc Trop Med Hyg (1992) 0.84
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol (2011) 0.84
[Study of pancreatic proteases II. --Determination of chymotrypsin by succinyl-phenylalanine-p-nitroanilide and its applications]. Ann Biol Clin (Paris) (1968) 0.84
Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection. J Med Virol (1997) 0.84
[Delirious states in elderly persons. Therapeutic modalities]. Presse Med (2003) 0.84
Extracapillary proliferative glomerulonephritis so-called malignant glomerulonephritis. Adv Nephrol Necker Hosp (1972) 0.84
Zidovudine therapy and HIV encephalitis: a 10-year neuropathological survey. AIDS (1994) 0.83
[Pneumocystis carinii pneumonia in a kidney transplantation center in the proximity of an AIDS care unit]. Presse Med (1993) 0.83
Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces. Biomaterials (1993) 0.82
An ELISA method to measure total and specific human secretory IgA subclasses based on selective degradation by IgA1-protease. J Immunol Methods (2000) 0.82
World Health Organization clinical case definition for AIDS in Africa: an analysis of evaluations. East Afr Med J (1992) 0.82
Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol (1992) 0.82
Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4. J Clin Immunol (1997) 0.81
Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy. Eur J Clin Microbiol Infect Dis (2011) 0.81
Coxiella burnetii infection among HIV-1-infected people living in Paris, France. AIDS (1993) 0.81
[Description of a computer system for the emergency medical laboratory (author's transl)]. J Clin Chem Clin Biochem (1980) 0.81
The HIV wasting syndrome. Muscle Nerve (1992) 0.81
Lack of HHV-8 DNA sequences in sarcoid tissues of French patients. Chest (1998) 0.80
Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol (1996) 0.80
IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol (2006) 0.80
[Efficacy of intravenous immunoglobulin in the treatment of Birdshot retinochoroiditis]. J Fr Ophtalmol (2002) 0.80
Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire. AIDS (2000) 0.80
Screening blood donations for hepatitis C in Central Africa: analysis of a risk- and cost-based decision tree. Med Decis Making (1999) 0.80
[Fats with short and medium chains. Physiological, biochemical, nutritional, and therapeutic aspects]. Ann Nutr Aliment (1970) 0.80
[Measurement of the trypsin inhibition capacity of human serum]. Clin Chim Acta (1966) 0.79
Secretory component is bound to the paraproteins in sera of IgA and IgM gammopathies. Scand J Immunol (1992) 0.79